Ortho-R is being studied in rotator cuff tear repair. OrthoRTI plans to enroll 78 patients for its phase 1 and 2 clinical trials in the fall.
The trial was put on hold in June, and OrthoRTI submitted data related to the drug’s chemistry, manufacturing and control to the FDA in July.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
